B

Better Therapeutics

35 employees

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Basic info

Industry

biotechnology

Sectors

cognitive behavioral therapy
Biotechnology
hyperlipidemia
behavioral science
mHealth
prescription digital therapeutics
heart disease
research and development
cardiometabolic conditions
Information Technology
digital therapeutics
prescription software
Artificial Intelligence
neuroscience
disease reversal
Health Care
digital health
type 2 diabetes
lifestyle medicine
behavioral psychology
chronic disease
Therapeutics
diabetes
hypertension

Date founded

2015

Funding rounds raised

Total raised

$70M

from 4 investors over 4 rounds

B

Better Therapeutics raised $70M on October 29, 2021

Investors: Sectoral Asset Management, Farallon Capital Management and Monashee Investment Management LLC

B

Better Therapeutics raised $50M on August 25, 2021

Investors: Hercules Capital, Inc.

FAQ